Latest News & Features
Refine Search
Americas
Allergan has boosted its focus on women’s health with the acquisition of Repros Therapeutics, a development stage biopharmaceutical company. 13 December 2017
Americas
Forest Laboratories, a subsidiary of Allergan, has failed in its attempt to overturn a district court ruling in its patent battle with Teva. 13 December 2017
Big Pharma
Teva has dropped its litigation over two US patents against Mylan, after a district court adopted Mylan’s interpretation of the patents. 12 December 2017
Americas
Gilead Sciences has built on its acquisition of cell therapy company Kite Pharma with another purchase. 12 December 2017
Big Pharma
The UK government has announced a deal between the life sciences sector and the government, aimed at ensuring that the “next wave of breakthrough treatments” and innovative medical research and technologies are created in the country. 11 December 2017
Biotechnology
The English High Court has sided with Eli Lilly in holding that its UK-related claims in a patent case can be heard together with its European-based arguments in the UK. 8 December 2017
Americas
Non-profit group the Initiative for Medicines, Access & Knowledge (I-MAK) has brought another two patent challenges against Gilead over its hepatitis C medicine sofosbuvir. 8 December 2017
Big Pharma
An advocate general has said that regulatory authorities in “concerned” EU member states handling drug marketing authorisations are co-responsible for approved documents on data exclusivity. 7 December 2017
Americas
An IBM counsel has discussed how companies can harness their IP and gave an overview of the impact of artificial intelligence on healthcare. 7 December 2017
Big Pharma
An end of procedure notice issued by a reference EU member state before the expiry of a basic patent may not be treated as equivalent to a marketing authorisation. 7 December 2017